Completed
A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma
NCT01781572
- Conditions
- Locally Advanced or Metastatic NRAS Mutant Melanoma
- Locations
-
- University of California, Dept of Oncology San Francisco, California, United States
- California Pacific Medical Center Onc Dept San Francisco, California, United States
- Karmanos Cancer Institute Dept of Oncology Detroit, Michigan, United States
- Memorial Sloan Kettering Cancer Center Dept Oncology New York, United States